Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0287102 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Peggy Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Immunology, Keck School of Medicine at USC, Los Angeles, California, United States of America. Hauptthemen laut MEDLINE: Rifamycins, Acinetobacter baumannii. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Recently, we reported rifabutin hyper-activity against Acinetobacter baumannii . We sought to characterize if any additional rifamycins (n = 22) would also display hyper-activity when tested in iron-limited media against A . baumannii , K . pneumoniae , and E . coli . MICs were determined against representative clinical isolates using the iron-limited media RPMI-1640. Only rifabutin was hyperactive against A . baumannii .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Microbiology and Immunology, Keck School of Medicine at USC, Los Angeles, California, United States of America.
- Department of Life Science, University of Modena and Reggio Emilia, Modena, Italy.
- Los Angeles General Medical Center, Los Angeles, California, United States of America.
ORCID-Profile: Emilia Caselli, Brian Luna
Förderung
- NIAID NIH HHS
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Lu, P., Alletto, F., Lee, B., Burk, E., Martinez, J., Prati, F., Caselli, E., Spellberg, B., & Luna, B. (2023). Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates. PLOS ONE. https://doi.org/10.1371/journal.pone.0287102
Vancouver
Lu P, Alletto F, Lee B, Burk E, Martinez J, Prati F, et al. Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates. PLOS ONE. 2023. doi:10.1371/journal.pone.0287102
BibTeX
@article{Lu2023,
author = {Lu, Peggy and Alletto, Francesco and Lee, Bosul and Burk, Elizabeth and Martinez, Jasmine and Prati, Fabio and Caselli, Emilia and Spellberg, Brad and Luna, Brian},
title = {Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0287102}
}
EUVIMED